Apple (NASDAQ:AAPL) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $212.92 price target on the stock, up previously from $205.00. This represents a 5.5% downside from the current price of $225.38. |
AMETEK (NYSE:AME) was downgraded by analysts at TD Cowen from a "hold" rating to a "sell" rating.The current price is $166.38. |
AMN Healthcare Services (NYSE:AMN) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $48.00 price target on the stock, down previously from $65.00. This represents a 27.6% upside from the current price of $37.63. |
Amazon.com (NASDAQ:AMZN) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $183.00 price target on the stock, down previously from $225.00. This represents a 0.6% upside from the current price of $181.89. |
American Express (NYSE:AXP) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $286.00 price target on the stock, up previously from $268.00. This represents a 4.1% upside from the current price of $274.78. |
Brookdale Senior Living (NYSE:BKD) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $6.00 price target on the stock, down previously from $7.75. This represents a 3.4% upside from the current price of $5.80. |
Celanese (NYSE:CE) was downgraded by analysts at KeyCorp from an "overweight" rating to a "sector weight" rating.The current price is $135.27. |
Ciena (NYSE:CIEN) was downgraded by analysts at JPMorgan Chase & Co. from an "overweight" rating to a "neutral" rating. They now have a $65.00 price target on the stock. This represents a 1.1% upside from the current price of $64.30. |
Comerica (NYSE:CMA) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $52.00 price target on the stock, down previously from $55.00. This represents a 10.9% downside from the current price of $58.35. |
Concentra Group Holdings Parent (NYSE:CON) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $24.00 price target on the stock, down previously from $30.50. This represents a 18.9% upside from the current price of $20.18. |
Charles River Laboratories International (NYSE:CRL) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $190.00 price target on the stock, down previously from $225.00. This represents a 1.8% upside from the current price of $186.60. |
Centuri (NYSE:CTRI) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating. They now have a $16.00 price target on the stock, down previously from $19.00. This represents a 2.8% upside from the current price of $15.57. |
Sprinklr (NYSE:CXM) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "underweight" rating. They now have a $7.00 price target on the stock, down previously from $10.00. This represents a 2.5% downside from the current price of $7.18. |
DuPont de Nemours (NYSE:DD) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $84.00 price target on the stock, down previously from $88.00. This represents a 2.2% downside from the current price of $85.91. |
Denali Therapeutics (NASDAQ:DNLI) was downgraded by analysts at Cantor Fitzgerald from an "overweight" rating to a "neutral" rating.The current price is $27.68. |
Evotec (NASDAQ:EVO) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $3.80 price target on the stock, down previously from $8.70. This represents a 12.1% upside from the current price of $3.39. |
Garmin (NYSE:GRMN) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $138.00 price target on the stock, down previously from $155.00. This represents a 15.1% downside from the current price of $162.61. |
Halozyme Therapeutics (NASDAQ:HALO) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $62.00 price target on the stock, up previously from $58.00. This represents a 11.2% upside from the current price of $55.78. |
Hershey (NYSE:HSY) was downgraded by analysts at Sanford C. Bernstein from an "outperform" rating to a "market perform" rating. They now have a $205.00 price target on the stock, down previously from $230.00. This represents a 8.9% upside from the current price of $188.33. |
Hershey (NYSE:HSY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $209.00 price target on the stock, down previously from $226.00. This represents a 11.0% upside from the current price of $188.33. |
Humana (NYSE:HUM) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating. They now have a $253.00 price target on the stock, down previously from $519.00. This represents a 9.3% upside from the current price of $231.42. |
Humana (NYSE:HUM) was downgraded by analysts at TD Cowen from a "buy" rating to a "hold" rating. They now have a $261.00 price target on the stock, down previously from $402.00. This represents a 12.8% upside from the current price of $231.42. |
Immunocore (NASDAQ:IMCR) was downgraded by analysts at Guggenheim from a "buy" rating to a "neutral" rating.The current price is $30.46. |
KB Home (NYSE:KBH) was downgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "underweight" rating. They now have a $83.00 price target on the stock, up previously from $80.00. This represents a 4.1% upside from the current price of $79.74. |
Lennar (NYSE:LEN) was downgraded by analysts at Wells Fargo & Company from an "overweight" rating to an "equal weight" rating. They now have a $190.00 price target on the stock, down previously from $205.00. This represents a 4.9% upside from the current price of $181.08. |
Portillo's (NASDAQ:PTLO) was downgraded by analysts at Stephens from an "overweight" rating to an "equal weight" rating. They now have a $13.00 price target on the stock. This represents a 2.9% upside from the current price of $12.63. |
Vista Outdoor (NYSE:VSTO) was downgraded by analysts at Monness Crespi & Hardt from a "buy" rating to a "neutral" rating.The current price is $43.78. |